Tyme Technologies, Inc.
(NASDAQ CM: TYME)
Rigrodsky Law, P.A. is investigating Tyme Technologies, Inc. (“Tyme”) regarding possible breaches of fiduciary duties and other violations of law related to Tyme’s agreement to be acquired by Syros Pharmaceuticals, Inc. (“Syros”). Under the terms of the agreement, Tyme’s shareholders will receive approximately 0.4312 shares of Syros common stock for each share of Tyme common stock they own.